Status:

UNKNOWN

Post Exposure Prophylaxis in Healthcare Workers Exposed to COVID-19 Patients

Lead Sponsor:

Hamad Medical Corporation

Conditions:

COVID 19

Eligibility:

All Genders

18-60 years

Phase:

PHASE2

PHASE3

Brief Summary

More cases of COVID-19 pandemic are being reported daily around the world. It is highly infectious and, over 7 million people have been infected and more than 400,000 people have died globally till th...

Detailed Description

More cases of COVID-19 pandemic are being reported daily around the world. It is highly infectious and, over 7 million people have been infected and more than 400,000 people have died globally till th...

Eligibility Criteria

Inclusion

  • 18 years or older, all healthcare workers in direct contact with COVID-19 patients (ex: physicians, nurses, pharmacists, etc.), the ability to swallow Oral medications, without any GI abnormalities that may affect absorption. Who agree to participate in the trial.

Exclusion

  • Allergy to HCQ.
  • Pregnancy or breastfeeding.
  • Known history of Retinal disease not related to Macular degeneration, or preexisting eye retinopathy.
  • Having a prior history of blood disorders such as aplastic anemia, agranulocytosis, leukopenia, or thrombocytopenia.
  • Having a prior history of glucose-6-phosphate dehydrogenase (G-6-PD) deficiency.
  • Having dermatitis, psoriasis, or porphyria.
  • History of lung disease or Pneumonia not related to COVID-19.
  • Taking CYP450 enzyme-inducing medications within 4 weeks of the start of taking HCQ (Ex: Phenytoin, Carbamazepine, Phenobarbital, Primidone or Oxcarbazepine.
  • Currently taking QT-prolonging medications, which may include Antiarrhythmics, Quinolones, Macrolides, select Antipsychotics and Antidepressants.
  • Team members planning to have major abdominal, thoracic, spine or CNS surgery during the protocol period

Key Trial Info

Start Date :

August 31 2020

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 31 2021

Estimated Enrollment :

500 Patients enrolled

Trial Details

Trial ID

NCT04437693

Start Date

August 31 2020

End Date

December 31 2021

Last Update

August 11 2020

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.